6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
23m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
56m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
56m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
56m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
56m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) — investor relations, events, news, and company updates on 6ix.

Latest News

Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026

Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis

Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Financials

Revenue

$677.56 M

Market Cap

$3.79 B

P/E Ratio

66.07

EPS

0.75

Community Chat

Ask AI